The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity

The transcription of HIV-1 (HIV) is regulated by complex mechanisms involving various cellular factors and virus-encoded transactivators. Poly(ADP-ribose) polymerase 1 (PARP-1) inhibition has emerged recently as a potent anti-inflammatory tool, since PARP-1 is involved in the regulation of some gene...

Full description

Bibliographic Details
Main Authors: Slava eRom, Nancy L Reichenbach, Holly eDykstra, Yuri ePersidsky
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00878/full
_version_ 1818649781308751872
author Slava eRom
Nancy L Reichenbach
Holly eDykstra
Yuri ePersidsky
author_facet Slava eRom
Nancy L Reichenbach
Holly eDykstra
Yuri ePersidsky
author_sort Slava eRom
collection DOAJ
description The transcription of HIV-1 (HIV) is regulated by complex mechanisms involving various cellular factors and virus-encoded transactivators. Poly(ADP-ribose) polymerase 1 (PARP-1) inhibition has emerged recently as a potent anti-inflammatory tool, since PARP-1 is involved in the regulation of some genes through its interaction with various transcription factors. We propose a novel approach to diminish HIV replication via PARP-1 inhibition using human primary monocyte-derived macrophages (MDM) as an in vitro model system. PARP-1 inhibitors were able to reduce HIV replication in MDM by 60-80% after 7 days infection. Long Terminal Repeat (LTR) acts as a switch in virus replication and can be triggered by several agents such as: Tat, tumor necrosis factor α (TNFα), and phorbol 12-myristate 13-acetate (PMA). Overexpression of Tat in MDM transfected with an LTR reporter plasmid led to a 4.2-fold increase in LTR activation; PARP inhibition resulted in 70% reduction of LTR activity. LTR activity, which increased 3-fold after PMA or TNFα treatment, was reduced by PARP inhibition (by 85-95%). MDM treated with PARP inhibitors showed 90% reduction in NFκB activity (known to mediate PMA- and TNFα-induced HIV LTR activation). Cytoskeleton rearrangements are important in effective HIV-1 infection. PARP inactivation reduced actin cytoskeleton rearrangements by affecting Rho GTPase machinery. These findings suggest that HIV replication in MDM could be suppressed by PARP inhibition via NFκB suppression, diminution of LTR activation and its effects on the cytoskeleton. PARP appears to be essential for HIV replication and its inhibition may provide a potent approach to treatment of HIV infection.
first_indexed 2024-12-17T01:39:46Z
format Article
id doaj.art-b3924f567ff54afaa44c46ff73784676
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-17T01:39:46Z
publishDate 2015-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-b3924f567ff54afaa44c46ff737846762022-12-21T22:08:21ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2015-08-01610.3389/fmicb.2015.00878151304The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activitySlava eRom0Nancy L Reichenbach1Holly eDykstra2Yuri ePersidsky3Temple University School of MedicineTemple University School of MedicineTemple University School of MedicineTemple University School of MedicineThe transcription of HIV-1 (HIV) is regulated by complex mechanisms involving various cellular factors and virus-encoded transactivators. Poly(ADP-ribose) polymerase 1 (PARP-1) inhibition has emerged recently as a potent anti-inflammatory tool, since PARP-1 is involved in the regulation of some genes through its interaction with various transcription factors. We propose a novel approach to diminish HIV replication via PARP-1 inhibition using human primary monocyte-derived macrophages (MDM) as an in vitro model system. PARP-1 inhibitors were able to reduce HIV replication in MDM by 60-80% after 7 days infection. Long Terminal Repeat (LTR) acts as a switch in virus replication and can be triggered by several agents such as: Tat, tumor necrosis factor α (TNFα), and phorbol 12-myristate 13-acetate (PMA). Overexpression of Tat in MDM transfected with an LTR reporter plasmid led to a 4.2-fold increase in LTR activation; PARP inhibition resulted in 70% reduction of LTR activity. LTR activity, which increased 3-fold after PMA or TNFα treatment, was reduced by PARP inhibition (by 85-95%). MDM treated with PARP inhibitors showed 90% reduction in NFκB activity (known to mediate PMA- and TNFα-induced HIV LTR activation). Cytoskeleton rearrangements are important in effective HIV-1 infection. PARP inactivation reduced actin cytoskeleton rearrangements by affecting Rho GTPase machinery. These findings suggest that HIV replication in MDM could be suppressed by PARP inhibition via NFκB suppression, diminution of LTR activation and its effects on the cytoskeleton. PARP appears to be essential for HIV replication and its inhibition may provide a potent approach to treatment of HIV infection.http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00878/fullHIV-1LTRNeuroAIDSPARPNFκB
spellingShingle Slava eRom
Nancy L Reichenbach
Holly eDykstra
Yuri ePersidsky
The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
Frontiers in Microbiology
HIV-1
LTR
NeuroAIDS
PARP
NFκB
title The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_full The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_fullStr The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_full_unstemmed The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_short The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_sort dual action of poly adp ribose polymerase 1 parp 1 inhibition in hiv 1 infection hiv 1 ltr inhibition and diminution in rho gtpase activity
topic HIV-1
LTR
NeuroAIDS
PARP
NFκB
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00878/full
work_keys_str_mv AT slavaerom thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT nancylreichenbach thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT hollyedykstra thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT yuriepersidsky thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT slavaerom dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT nancylreichenbach dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT hollyedykstra dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT yuriepersidsky dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity